In 2025, the New Zealand market value stood at USD 1.10 billion.
Our forecast scenarios estimate the New Zealand Infusion Services Market will be USD 1.86 billion by 2033, registering a CAGR of 6.8% over the forecast horizon.
Centralized funding through Te Whatu Ora supports equitable infusion access, though limited population scale constrains overall expansion pace.
Ministry of Health cancer statistics show ongoing treatment activity across district networks, sustaining consistent systemic therapy delivery.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]